MIDDLE EAST PHARMACEUTICAL INDUSTRIES TADAWUL:4016:
AVALON PHARMA - SIGNING A NON-BINDING MEMORANDUM OF UNDERSTANDING WITH BENTA SAS
MIDDLE EAST PHARMACEUTICAL INDUSTRIES - MOU TO ESTABLISH STRATEGIC PARTNERSHIP IN SAUDI ARABIA
Avalon Pharma Signs Non-Binding Memorandum Of Understanding With Benta Sas
Middle East Pharmaceutical Industries Company on 6ix
Earlier from Middle East Pharmaceutical Industries
- Avalon Pharma Q3 Profit SAR 8.28 Mln
- ZAWYA: Saudi's Avalon Pharma renews $14mln credit with Saudi Investment Bank
- Middle East Pharmaceutical Industries H2 Dividend Per Share SAR 1.25
Later from Middle East Pharmaceutical Industries
- Avalon Pharma Grants Three Bonus Shares For Every Four Shares Held
- Avalon Pharma Contract Sign Off With Bio-Thera Solutions
- Avalon Pharma FY Profit 97.01 Mln Riyals
- Avalon Pharma H2 Dividend Per Share SAR 1.32
- Avalon Pharma Appoints Ahmad Shaher Al Tabbaa As Chairman
Follow Middle East Pharmaceutical Industries into a list and get an email when it puts out news.
Follow Middle East Pharmaceutical Industries